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Abstract. It has been hypothesized that Helicobacter
pylori (Hp) infection may contribute to reduced
stature, risk of hypertension or obesity. The aim was
to evaluate body indices in Hp positive and negative
persons. A total of 2436 subjects (4–100 years old)
were tested for Hp status by
13C-urea breath test.
Data on height and weight were collected for 84%,
and blood pressure for 80% of the study subjects. The
prevalence of Hp infection was 41.6%. The odds ratio
for a 10-year increase in age was 1.21 (95% CI 1.17–
1.25, p-value <0.001). Statistically signiﬁcant nega-
tive association of Hp positivity with body height was
most pronounced in the younger age groups, while a
positive association of Hp positivity with body mass
index was only seen in those aged 15+ years. There
was a negative eﬀect of Hp positivity on systolic and
diastolic blood pressure in subjects below 25 and a
relatively strong positive eﬀect on blood pressure in
subjects over 65 years. Residual confounding by so-
cial characteristics as a possible explanation for the
associations of Hp positivity with height and blood
pressure cannot be excluded. Unmeasured factors
related to social and family environment may cause
the apparent association between Hp positivity and
children’s growth and blood pressure.
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Introduction
Helicobacter pylori (Hp) has been recognized as one
of the most common chronic bacterial infection in
the world. Its prevalence is high in developing
countries (80–90%) and lower in developed ones
(<40%) [1, 2]. Hp infection is acquired during early
childhood in most individuals. The infection lasts
several decades or even life long, with a low spon-
taneous eradication rate. Hp is a cause of chronic
gastritis and may be closely associated with a num-
ber of extragastric diseases [2, 3]. In general, any
chronic inﬂammatory conditions can inﬂuence
health status remote to the site of inﬂammation. It
has been suggested that chronic Hp infection may
predispose subjects to the development of malnu-
trition [4, 5] and growth delay in children [4–7]. On
the other hand it has been hypothesized that chronic
Hp infection may contributed to hypertension
[8–11], lipid metabolism disturbance [9, 12] and
obesity [9]. However, published results are rather
controversial in current literature. Other authors
have found no association of Hp infection or short
stature [13–15], hypertension [16, 17], nutritional
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DOI 10.1007/s10654-006-9090-1status [15, 18] or obesity [19, 20]. These papers are
diﬃcult to be compared as they diﬀer in the indi-
viduals studied, design and number of subjects, the
diagnostic methods used (serology,
13C-urea breath
test, stool antigen tests) and coming from both
developed and developing countries. The Czech
Republic has medium prevalence of Helicobacter
pylori infection (40%) and thus diﬀers from both
developed and developing countries. The aim of this
study was to evaluate body indices and basic vital
signs in Hp positive and negative persons in a rep-
resentative sample of the general Czech population.
Subjects and methods
Subjects
Hp status was investigated in 2436 persons older than
4 years. These subjects were chosen in a two-step
random selection, carried out centrally, in a general
population of 30,012 individuals. Nineteen general
practitioners (12 for adults and 7 for children) took
part in this Project. Recruitment areas ﬁtted well with
geographic distribution of population in the Czech
Republic, covering cities and towns (8 GPs), smaller
towns with surrounding villages (8 GPs) and rural
areas (3 GPs). There were no preliminary exclusion
criteria.
For 2425 (>99.5%) of these, results of two test
samples were available. For the purpose of the cur-
rent analysis 1,003 subjects who had positive results
in both tests or one positive and one borderline (or
missing) result are classiﬁed as Hp positive. Twenty-
ﬁve (<1%) subjects with clearly discrepant results
(one positive and one negative) were excluded from
the evaluation. The rest of the study subjects are
considered Hp negative for the purpose of the current
analysis.
Urea breath test
Urea breath tests were performed in the morning
after overnight fasting. Citric acid solution (3 g dis-
solved in 150 ml of still water) was used as a test
drink. All subjects ingested 100 mg
13C-urea for
adults (Helicobacter Test Hp Plus, Utandningstester i
Sverige AB, Go ¨ teborg, Sweden) or 75 mg
13C-urea
for children and adolescents (Helicobacter Test IN-
FAI, INFAI GmbH, Ko ¨ ln, Germany) dissolved in
50 ml of still water with 1 g citric acid. Baseline and
test breath samples were collected in duplicate at time
0 and after 30 min. Tubes with breath samples were
sent to a single analytical centre by post and mea-
sured within a 1-week period. Breath samples were
analysed by means of isotope ratio mass spectrometry
(AP 2003, Analytical Precision, United Kingdom).
Cut-oﬀ was 3.5 (grey zone range 3.3–3.7).
Body indices and basic vital signs
Data on height and weight were collected at the
clinics for 84% of the study subjects. Overweight and
obesity in adults were deﬁned as body mass index of
25+ and 30+ kg/m
2, respectively. The deﬁnitions of
overweight and obesity in children and adolescents
aged 4–17 years are based on age and gender-speciﬁc
cut-oﬀ points developed by Cole et al. [21].
Systolic and diastolic blood pressure measure-
ments were performed by a trained nurse in a
standard manner [22] at the study clinics and were
completed for 80% of the study subjects. The blood
pressure was measured in the morning (from 8 to
12 a.m.). Hypertension in adults was deﬁned as
systolic blood pressure ‡140 and/or diastolic blood
pressure ‡90 mm Hg, according to the guidelines of
European Society of Hypertension-European Soci-
ety of Cardiology [22] and the reviewed WHO-
International Society of Hypertension guidelines
[23]. Hypertension in children and adolescents aged
4–17 years was deﬁned based on the age, gender and
height-speciﬁc criteria published by the National
High Blood Pressure Education Program Working
Group on High Blood pressure in Children and
Adolescents (2004) [24]. Analyses of associations of
Hp positivity with body size and blood pressure
were restricted to 79.8% of the sample with data on
height, weight, systolic and diastolic blood pressure
available. There were no statistically signiﬁcant dif-
ferences in the prevalence of Hp positivity, age,
gender or nationality between the subjects with all
data available and those who had missing data on
body size or blood pressure. The subjects excluded
from the analyses because of missing data on body
size or blood pressure tended, however, to be on
average more educated and were more likely to live
in large towns.
Questionnaires
Social characteristics are based on data from self-
completed questionnaires and include nationality
classiﬁed as Czech and other, place of residence
classiﬁed as ‘‘village’’, ‘‘small town with less than
20,000 inhabitants’’ and ‘‘larger town with more than
20,000 inhabitants’’ and highest level of education
achieved. The study subjects’ own education or their
parents’ education (if younger than 25 years or still
studying) are analysed as categorical variables with
four categories (basic or less, vocational training,
secondary education, university). Information on
social characteristics was available for 99% of the
study sample. Information on the study subjects’
smoking habits was also collected in the question-
naire, grouped into three categories of ‘‘never’’,
‘‘past’’ and current’’ smokers, and is used in the
analyses for those aged 15+.
68Statistical analysis
The data was analysed by univariate and multivariate
linearandlogisticregressionsasappropriate,usingthe
STATA package [25]. Multivariate analyses were re-
stricted to those subjects with all relevant data avail-
able. Results ofanalysesstratiﬁedbyagearepresented
in this paper to take account of the hypothesised
interactions with age of the study subjects.
Study approval and conﬁdentiality of data obtained
The study was approved by the local Ethics commit-
tee. All participants got detailed written information
about the Project in advance and signed written con-
sent (parents on behalf of their children). For all data
obtained, all personal identiﬁcation information was
deleted in compliance with the laws for the protection
of conﬁdentiality of the Czech Republic.
Results
Basic descriptive characteristics of the study sample
are presented in Table 1. The overall prevalence of
Hp positivity in our study was 41.6%. Hp positivity
was strongly associated with age of the study sub-
jects. The odds ratio for a 10-year increase in age was
1.21 (95% CI 1.17–1.25, p-value <0.001). There were
no statistically signiﬁcant gender diﬀerences in Hp
positivity. The age-adjusted odds ratio for Hp posi-
tivity in females compared to males was 0.95 (95% CI
0.81–1.13, p-value 0.577). Only four subjects (<0.2%)
were on long term proton pump inhibitors treatment
at the time of our study, of whom two subjects tested
as Hp positive and two as Hp negative. Exclusion of
these four subjects from analysis did not aﬀect the
results appreciably.
We observed a relatively strong and statistically
signiﬁcant negative association of Hp positivity with
body height, which was most pronounced, and
statistically signiﬁcant, in the younger age groups
(Table 2). Some of this association was explained by
further adjustments for place of residence, education
and nationality (Table 2).
Hp positivity was also associated with a slightly
lower body mass index in children below 15 years
(Table 2) and with a higher mean body mass index in
subjects over 15 years (Table 2). The associations of
Hp positivity with body mass index were relatively
little aﬀected by adjustments for social characteristics
or smoking (Table 2).
Analyses of overweight and obesity showed a
statistically signiﬁcantly lower prevalence of over-
weight in Hp positive children and a higher preva-
lence of overweight and obesity in adults that was of
borderline statistical signiﬁcance (Table 3).
There were marked diﬀerences between age groups
in how Hp positivity was related to systolic and
diastolic blood pressure. We observed a strong
negativeeﬀectofHppositivityonsystolicanddiastolic
blood pressure in subjects below 25 years of age and a
relatively strong positive eﬀect on blood pressure in
subjects aged 65+ years (Table 4). While the strength
of the association between Hp positivity and blood
pressure in children was nearly halved on adjustment
for body mass index and social characteristics, the
strength of the positive association between Hp
positivityandbloodpressureinoldestsubjectswasless
aﬀected by adjustments for body mass index, social
characteristics and smoking, and the negative associ-
ation between Hp positivity and blood pressure in
subjects aged 15–24 became stronger.
Analyses of Hp positivity with hypertension yiel-
ded results broadly consistent with analyses of blood
pressure (Table 5). Fully adjusted analyses did not
show statistically signiﬁcant associations between Hp
positivity and hypertension, with the exception of a
positive association of borderline statistical signiﬁ-
cance seen in the oldest group (Table 5). The statis-
tical interactions of Hp positivity with age in their
eﬀect on blood pressure and hypertension were sta-
tistically signiﬁcant, suggesting diﬀerential eﬀects,
and possibly also diﬀerent mechanisms, by which Hp
positivity is related to blood pressure in diﬀerent age
groups.
We did not observe any statistically signiﬁcant
eﬀects of Hp positivity on pulse rate in any age group
(data not shown).
Discussion
The overall prevalence of Hp infection was 41.6% in
this study. Hp positivity was strongly associated with
age of the study subjects. We observed a relatively
strong and statistically signiﬁcant negative associa-
tion of Hp positivity with body height, which was
most pronounced, and statistically signiﬁcant, in the
youngest age groups (Table 2). Several epidemiolog-
ical studies showed association between Hp infection
and short growth in children [4–7]. However, con-
tradictory data are available on this topic, as other
authors did not ﬁnd any relation [13–15]. Results and
conclusions of all published papers (including our
ﬁndings) must be assessed with caution. It is neces-
sary to distinguish intrinsic shortness and delayed or
attenuated growth. Several factors can inﬂuence
growth and stature, including chronic inﬂammation,
nutrition and several gastrointestinal diseases [26].
Thomas et al. [4] followed 190 children in Gambia
from their birth in two cohort studies. Early coloni-
sation with Hp was associated with weight and
growth deﬁcit compared to non-infected individuals.
No socioeconomic or demographic confounding
variables were identiﬁed these ﬁndings. The deﬁcit
was no longer detectable when the children reached
age of 5–8 years [4]. Bravo et al. [27] studied 347 Hp
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72negative children aged 12–60 months (tested by
13C-
urea breath test). During the prospective follow-up
(2.5 years) 105 (30%) children, who were uninfected
at the start of the study, acquired Hp infection.
Growth velocity in infected children was signiﬁcantly
reduced (0.5 cm per year) [27]. Passaro et al. [28]
found that even 2 months after eradication of Hp
(assessed by seroconversion) there was a slowing of
weight gain in young children. Reasons for this
ﬁnding remain unclear. However, Naﬁcy et al. [15]
did not ﬁnd such an association among young sero-
converted Egyptian children. Hp infection was not
associated with malnutrition either [15]. In a study
from Guatemala [18], 211 girls aged 5–10 were
investigated and their height-for-age was signiﬁcantly
decreased with both Hp infection and lower income
level. However, Hp infection did not aﬀect nutritional
status of those individuals [18]. Sood et al. [29] hav-
ing assessed 257 children in a US study, found Hp
positive children shorter and lighter compared with
non-infected ones. They concluded that diﬀerences in
anthropometry might be due to socioeconomic and
ethnic factors rather that Hp infection [29].
Perri et al. [7] found a strong relationship between
Hp infection and short stature in older children, poor
socio-economic status and household overcrowding.
Several hypotheses were given to explain this associ-
ation: chronic systemic release of cytokines (tumour
necrosis factor alfa in particular) aﬀecting growth,
low energy intake and/or malnutrition and low socio-
economic background may be the pathogenic
mechanisms responsible for short stature [7]. Choe
et al. [30] found a signiﬁcantly lower height among
532 healthy children aged 10–15 having both Hp
infection and iron deﬁciency anaemia. Authors con-
cluded that Hp infection accompanied by iron deﬁ-
ciency anaemia, rather than Hp infection per se,
might delay pubertal growth [30]. According to other
studies both Hp infection and short stature are two
non-related consequences of low socio-economic
status [16]. Growth delay at around the time of
puberty in Hp positive children was also found by
other authors [6, 7, 31, 32] and could be explained as
delayed pubertal growth spurting. Delayed menarche
in Hp positive girls [33] is consistent with these ﬁnd-
ings. Recently, Moayyedi et al. [34] found that Hp
infected women (aged 40–49) were 1.4 cm shorter
than uninfected ones. Statistically signiﬁcant diﬀer-
ence persisted even after adjusting for age, ethnicity,
childhood and present socio-economic status. Despite
this, authors concluded that this reduced adult height
might be due to residual confounding [34]. Similar
ﬁndings of reduced height in Hp positive women (but
not men) compared to Hp negative ones were de-
scribed also by Murray et al. [35]. In this large pop-
ulation-based study (4742 subjects aged 12–64) Hp
was more common in men (61%) than women (55%)
[35].
In our study, Hp positivity was associated with a
slightly lower body mass index in children below
15 years and with a higher mean body mass index
and a higher prevalence of overweight and obesity in
older subjects. In literature, there are both positive [9,
33] and negative [19, 20] reports on association of Hp
infection and higher body mass index and/or obesity.
Hp eradication has induced increase in body mass
index in Japanese industrial workers [36]. According
to another studies, Hp eradication improved some
nutritional parameters, including gain in body weight
[37].
We have also found marked diﬀerences between
age groups in how Hp positivity was related to sys-
tolic and diastolic blood pressure. We observed a
strong negative eﬀect of Hp positivity on systolic and
diastolic blood pressure in subjects below 25 years of
age and a relatively strong positive eﬀect on blood
Table 5. The eﬀect of Helicobacter pylori positivity on hypertension, adjusted for age and gender; with additional
adjustments for body mass index and social characteristics
Hypertension
a
Prevalence (%) Odds ratio with 95% CI and p-value
Age: Hp
positive
Hp
negative
Adjusted for exact
age and gender
+ Body
mass index
+ Social
characteristics
+ Smoking
4–14 years
(n = 379)
13.8 19.5 0.65
(0.36,1.19) 0.161
0.68
(0.37,1.24) 0.210
0.72
(0.37,1.38) 0.324
–
15–24 years
(n = 327)
10.1 10.5 0.92
(0.41,2.08) 0.852
0.80
(0.35,1.84) 0.601
0.64
(0.26,1.56) 0.326
0.59
(0.24,1.48) 0.264
25–64 years
(n = 757)
46.5 39.5 1.02
(0.74,1.40) 0.899
0.96
(0.69,1.34) 0.830
0.86
(0.61,1.21) 0.377
0.84
(0.60,1.19) 0.337
65+ years
(n = 421)
81.6 72.7 1.62
(1.02,2.58) 0.041
1.58
(0.98,2.54) 0.058
1.53
(0.94,2.50) 0.089
1.56
(0.95,2.56) 0.076
aSystolic blood pressure ‡140 mm Hg and/or diastolic blood pressure ‡90 mm Hg in adults; age-speciﬁc cut-oﬀ points for
children and adolescents based on National High Blood Pressure Education Program Working Group on High Blood
pressure in Children and Adolescents (Ref. 24).
Note: social characteristics include: education (own or parental, if younger than 25 years), nationality and place of residence.
73pressure in subjects over 65-year old (Tables 4 and 5).
Controversial data have been published in literature
on the association of Hp infection and hypertension
with both positive [8–11] and negative [16, 17] results.
In a large community-based cross sectional study
(1634 Hp positive and 3267 Hp negative persons out
of 10,537 subjects enrolled), Hp infection had little
eﬀect on blood pressure in the general population,
mean systolic blood pressure was higher in Hp in-
fected individuals than in those who were not infected
and, although this was signiﬁcant statistically, the
authors concluded that it was unlikely to be clinically
important and might be explained by unknown
residual confounding factors [17]. Migneco et al. [10]
demonstrated a signiﬁcant decrease in blood pressure
values (in particular in the diastolic one) after suc-
cessful Hp eradication. There are several methodo-
logical diﬃculties in carrying out studies to determine
possible relationship between Hp infection and raised
blood pressure, there are several other factors that
must be considered (weight gain, salt intake, aging,
co-morbidity, antihypertensive therapy, compliance
of patients etc.) [38]. We can speculate that a negative
eﬀect of Hp infection on blood pressure is markedly
expressed (in the relative absence of other factors) in
younger adults while other factors mentioned above
dictate blood pressure in older subjects, both Hp
positive and negative.
We cannot exclude residual confounding by social
characteristics as a possible explanation for the
associations of Hp positivity with height and blood
pressure reported in our paper, especially in children.
It is plausible that unmeasured factors related to so-
cial and family environment may cause the apparent
association between Hp positivity and children’s
growth and blood pressure. On the other hand,
associations of Hp positivity with overweight and
hypertension in older subjects seem relatively little
aﬀected by adjustments for social characteristics or
smoking in our study, and the respective underlying
mechanisms should be further explored.
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